Novus Biologicals products are now on bio-techne.com

TSLPR/CRLF2 Antibody

Images

 
Mouse splenocytes were stained with Goat Anti-Mouse TSLP R Antigen Affinity-purified Polyclonal Antibody (Catalog # AF546, filled histogram) or control antibody (Catalog # AB-108-C, open histogram), followed by ...read more
Recombinant Mouse TSLP (Catalog # 555-TS) stimulates proliferation in the BaF3 mouse pro‑B cell line transfected with mouse IL‑7 R alpha /CD127 in a dose-dependent manner (orange line). Proliferation elicited by ...read more

Product Details

Summary
Reactivity MuSpecies Glossary
Applications WB, Flow, B/N, CyTOF-ready
Clonality
Polyclonal
Host
Goat
Conjugate
Unconjugated
Concentration
LYOPH

Order Details

View Available Conjugates
View Available Formulations
Novus Biologicals is part of Bio-Techne

Shop this product on bio-techne.com

TSLPR/CRLF2 Antibody Summary

Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse TSLP R
Ala20-Leu233
Accession # BAA92159
Specificity
Detects mouse TSLP R in direct ELISAs and Western blots.
Source
N/A
Isotype
IgG
Clonality
Polyclonal
Host
Goat
Gene
CRLF2
Purity Statement
Antigen Affinity-purified
Endotoxin Note
<0.10 EU per 1 μg of the antibody by the LAL method.
Innovator's Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.

Applications/Dilutions

Dilutions
  • CyTOF-ready
  • Flow Cytometry 2.5 ug/10^6 cells
  • Neutralization 0.2-0.6 ug/mL
  • Western Blot 0.1 ug/mL
Publications
Read Publications using
AF546 in the following applications:

Packaging, Storage & Formulations

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Preservative
No Preservative
Concentration
LYOPH
Reconstitution Instructions
Reconstitute at 0.2 mg/mL in sterile PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for TSLPR/CRLF2 Antibody

  • CRL2
  • CRL2cytokine receptor CRL2 precusor
  • CRLF2
  • CRLF2Y
  • CRLM-2
  • Cytokine receptor-like 2
  • cytokine receptor-like factor 2
  • ILXR
  • IL-XR
  • P2RY8/CRLF2 fusion
  • PCOR1
  • Thymic stromal lymphopoietin protein receptor
  • thymic stromal lymphopoietin receptor
  • thymic stromal-derived lymphopoietin receptor
  • TSLP R
  • TSLP receptor
  • TSLPR

Background

TSLP R, also named Delta (1) and CRLM-2 (2) (cytokine receptor-like module-2), was originally cloned as a novel type 1 cytokine receptor with similarity to the common gamma chain. It was subsequently identified to be a subunit of the cellular receptor for the IL-7-like cytokine TSLP and termed TSLP R (3). The TSLP R cDNA encodes a 359 amino acid (aa) residue type 1 membrane protein with a 24 aa residue signal peptide, a 206 aa residue extracellular domain that showed 24% sequence identity with the mouse common gamma receptor, a 23 aa residue transmembrane domain, and a 106 aa residue cytoplasmic domain. The cytoplasmic domain of TSLP R contains a membrane-proximal box1 motif which is known to be important for association with JAKs. An alternatively spliced mRNA variant encoding a soluble TSLP R has also been reported (2). TSLP R expression is ubiquitous in the immune and hematopoietic cells, but is up-regulated in Th2-skewed cells. Cells expressing TSLP R alone bind TSLP with low affinity. Co-expression of TSLP R and IL-7 R alpha is required for high-affinity TSLP binding and signal transduction (3, 4).

  1. Fujio, K. et al. (2000) Blood 95:2204.
  2. Hiroyama, T. et al. (2000) Biochem. Biophys. Res. Commun. 272:224.
  3. Park, L.S. et al. (2000) J. Exp. Med. 192:659.
  4. Pandey, A. et al. (2000) Nat. Immunol. 1:59.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Customers Who Viewed This Item Also Viewed...

1398-TS/CF
Species: Hu
Applications: BA
207-IL
Species: Hu
Applications: BA
NBP2-59451
Species: Hu
Applications: ELISA, Flow, ICC/IF, MiAr, WB
6507-IL/CF
Species: Hu
Applications: BA
NBP1-19371
Species: Ca, Hu, Mu, Po, Rb, Rt
Applications: Dual ISH-IHC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, Simple Western, WB
AF2168
Species: Hu, Mu
Applications: ChIP, Simple Western, WB
AF1584
Species: Hu, Mu
Applications: CyTOF-ready, ICC, IP, ICFlow, KO, Simple Western, WB
AF4984
Species: Hu
Applications: ChIP, CyTOF-ready, ICC, ICFlow, Simple Western, WB
DY413
Species: Mu
Applications: ELISA
MAB4260
Species: Hu, Mu, Rt
Applications: CyTOF-ready, ICC, IHC, ICFlow, Simple Western, WB
NBP1-72042
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, PEP-ELISA, WB
AF284
Species: Hu
Applications: CyTOF-ready, Flow, Neut, WB
DDX0700P-100
Species: Ca, Hu
Applications: B/N, Flow, IP
202-IL
Species: Hu
Applications: BA
MAB10541
Species: Hu
Applications: CyTOF-ready, Flow, ICC, Neut
DY417
Species: Mu
Applications: ELISA
AF546
Species: Mu
Applications: WB, Flow, B/N, CyTOF-ready

Publications for TSLPR/CRLF2 Antibody (AF546)(18)

We have publications tested in 1 confirmed species: Mouse.

We have publications tested in 4 applications: Flow Cytometry, IHC, Neutralization, Western Blot.


Filter By Application
Flow Cytometry
(3)
IHC
(1)
Neutralization
(2)
Western Blot
(2)
All Applications
Filter By Species
Mouse
(6)
All Species
Showing Publications 1 - 10 of 18. Show All 18 Publications.
Publications using AF546 Applications Species
Qi Cao, Ruifeng Wang, Zhiguo Niu, Titi Chen, Farhana Azmi, Scott A. Read et al. Type 2 innate lymphoid cells are protective against hepatic ischaemia/reperfusion injury JHEP Reports 7/3/2023 [PMID: 37691688]
Sreeparna Chakraborty, Abhalaxmi Singh, Li Wang, Xinge Wang, Mark A. Sanborn, Zijing Ye et al. Trained immunity of alveolar macrophages enhances injury resolution via KLF4-MERTK-mediated efferocytosis Journal of Experimental Medicine 11/6/2023 [PMID: 37615937]
Rajachandran, S;Zhang, X;Cao, Q;Caldeira-Brant, AL;Zhang, X;Song, Y;Evans, M;Bukulmez, O;Grow, EJ;Nagano, M;Orwig, KE;Chen, H; Dissecting the spermatogonial stem cell niche using spatial transcriptomics Cell reports 7/1/2023 [PMID: 37393620]
NL Tran, LM Ferreira, B Alvarez-Mo, V Buttiglion, B Ferrini, P Zordan, A Monestirol, C Fagioli, E Bezzecchi, GM Scotti, A Esposito, R Leone, C Gnasso, A Brendolan, LG Guidotti, G Sitia Continuous sensing of IFNalpha by hepatic endothelial cells shapes a vascular antimetastatic barrier Elife, 2022-10-25;11(0):. 10/25/2022 [PMID: 36281643]
ES Kim, BH Yoon, SM Lee, M Choi, EH Kim, BW Lee, SY Kim, CG Pack, YH Sung, IJ Baek, CH Jung, TB Kim, JY Jeong, CH Ha Fecal microbiota transplantation ameliorates atherosclerosis in mice with C1q/TNF-related protein 9 genetic deficiency Experimental & Molecular Medicine, 2022-02-03;0(0):. 2/3/2022 [PMID: 35115674]
J Park, JW Lee, SH Kim, J Oh, WS Roh, SM Kim, CO Park, MG Lee, TG Kim Type 2 immunity plays an essential role for murine model of allergic contact dermatitis with mixed type 1/type 2 immune response Journal of dermatological science, 2021-10-06;0(0):. 2021-10-06 [PMID: 34763990] (Flow Cytometry, Mouse) Flow Cytometry Mouse
Al-Shaibi AA, Abdel-Motal UM, Hubrack SZ et al. Human AGR2 Deficiency Causes Mucus Barrier Dysfunction and Infantile Inflammatory Bowel Disease Cellular and Molecular Gastroenterology and Hepatology 2021-07-06 [PMID: 34237462]
Al-Shaibi AA, Abdel-Motal UM, Hubrack SZ et al. Human AGR2 Deficiency Causes Mucus Barrier Dysfunction and Infantile Inflammatory Bowel Disease Cellular and Molecular Gastroenterology and Hepatology 7/6/2021 [PMID: 34237462]
Daniela Regensburger, Clara Tenkerian, Victoria Pürzer, Benjamin Schmid, Thomas Wohlfahrt, Iris Stolzer et al. Matricellular Protein SPARCL1 Regulates Blood Vessel Integrity and Antagonizes Inflammatory Bowel Disease Inflammatory Bowel Diseases 8/19/2021 [PMID: 33393634]
Antonella Carambia, Cornelia Gottwick, Dorothee Schwinge, Stephanie Stein, Reinaldo Digigow, Muharrem Şeleci et al. Nanoparticle‐mediated targeting of autoantigen peptide to cross‐presenting liver sinusoidal endothelial cells protects from CD8 T‐cell‐driven autoimmune cholangitis Immunology 4/1/2021 [PMID: 33346377]
Show All 18 Publications.

Reviews for TSLPR/CRLF2 Antibody (AF546) (0)

There are no reviews for TSLPR/CRLF2 Antibody (AF546). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

Video Protocols

WB Video Protocol

FAQs for TSLPR/CRLF2 Antibody (AF546) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.
Read our latest blog and use the new citation tool on bio-techne.com

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Calculators

Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.

=
÷

Review this Product

Be the first to review our TSLPR/CRLF2 Antibody and receive a gift card or discount.

Bioinformatics

Gene Symbol CRLF2
Uniprot